Demant A/S (CPH: DEMANT)
285.60
-2.20 (-0.76%)
Aug 30, 2024, 4:59 PM CET
Demant Revenue
Demant had revenue of 11.09B DKK in the half year ending June 30, 2024, with 16.74% growth. This brings the company's revenue in the last twelve months to 22.84B, up 9.25% year-over-year. In the year 2023, Demant had annual revenue of 22.44B with 13.89% growth.
Revenue (ttm)
22.84B
Revenue Growth
+9.25%
P/S Ratio
2.76
Revenue / Employee
1.06M
Employees
21,623
Market Cap
62.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 22.44B | 2.74B | 13.89% |
Dec 31, 2022 | 19.71B | 1.80B | 10.05% |
Dec 31, 2021 | 17.91B | 3.44B | 23.75% |
Dec 31, 2020 | 14.47B | -477.00M | -3.19% |
Dec 31, 2019 | 14.95B | 1.01B | 7.24% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk A/S | 258.00B |
Coloplast A/S | 26.30B |
Genmab A/S | 19.02B |
Zealand Pharma A/S | 367.97M |
H. Lundbeck A/S | 20.67B |
H. Lundbeck A/S | 20.67B |
ALK-Abelló A/S | 5.18B |
Ambu A/S | 5.08B |